메뉴 건너뛰기




Volumn 325, Issue 2, 2012, Pages 147-154

Molecular crosstalk between the proteasome, aggresomes and autophagy: Translational potential and clinical implications

Author keywords

Aggresome; Autophagy; Bortezomib; Proteasome; Ubiquitin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BAFILOMYCIN A1; BORTEZOMIB; BRCA1 PROTEIN; BUTYRIC ACID; CHLOROQUINE; COLCHICINE; DEXAMETHASONE; DOXORUBICIN; HISTONE DEACETYLASE 6; HYDROXYCHLOROQUINE; MELPHALAN; NOCODAZOLE; OXALIPLATIN; PANOBINOSTAT; PROTEASOME; PROTEIN P62; RAPAMYCIN; ROMIDEPSIN; TUBERIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VINCA ALKALOID; VORINOSTAT; WORTMANNIN;

EID: 84865651506     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.06.016     Document Type: Review
Times cited : (43)

References (93)
  • 1
    • 39349083915 scopus 로고    scopus 로고
    • Adapting proteostasis for disease intervention
    • Balch W.E., Morimoto R.I., Dillin A., Kelly J.W. Adapting proteostasis for disease intervention. Science 2008, 319:916-919.
    • (2008) Science , vol.319 , pp. 916-919
    • Balch, W.E.1    Morimoto, R.I.2    Dillin, A.3    Kelly, J.W.4
  • 2
    • 33646127577 scopus 로고    scopus 로고
    • Molecular chaperones and protein quality control
    • Bukau B., Weissman J., Horwich A. Molecular chaperones and protein quality control. Cell 2006, 125:443-451.
    • (2006) Cell , vol.125 , pp. 443-451
    • Bukau, B.1    Weissman, J.2    Horwich, A.3
  • 3
    • 37649005234 scopus 로고    scopus 로고
    • Autophagy in the pathogenesis of disease
    • Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
    • (2008) Cell , vol.132 , pp. 27-42
    • Levine, B.1    Kroemer, G.2
  • 5
    • 0034578389 scopus 로고    scopus 로고
    • Aggresomes, inclusion bodies and protein aggregation
    • Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends in Cell Biology 2000, 10:524-530.
    • (2000) Trends in Cell Biology , vol.10 , pp. 524-530
    • Kopito, R.R.1
  • 6
    • 77953415635 scopus 로고    scopus 로고
    • The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib
    • Milano A., Perri F., Caponigro F. The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib. OncoTargets and Therapy 2009, 2:171-178.
    • (2009) OncoTargets and Therapy , vol.2 , pp. 171-178
    • Milano, A.1    Perri, F.2    Caponigro, F.3
  • 7
    • 41549133200 scopus 로고    scopus 로고
    • Proteasome inhibitors in cancer therapy: lessons from the first decade
    • Orlowski R.Z., Kuhn D.J. Proteasome inhibitors in cancer therapy: lessons from the first decade. Clinical Cancer Research 2008, 14:1649-1657.
    • (2008) Clinical Cancer Research , vol.14 , pp. 1649-1657
    • Orlowski, R.Z.1    Kuhn, D.J.2
  • 9
    • 0642349188 scopus 로고    scopus 로고
    • Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts
    • Williams S., Pettaway C., Song R., Papandreou C., Logothetis C., McConkey D.J. Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts. Molecular Cancer Therapeutics 2003, 2:835-843.
    • (2003) Molecular Cancer Therapeutics , vol.2 , pp. 835-843
    • Williams, S.1    Pettaway, C.2    Song, R.3    Papandreou, C.4    Logothetis, C.5    McConkey, D.J.6
  • 11
    • 33744832401 scopus 로고    scopus 로고
    • United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy
    • Kane R.C., Farrell A.T., Sridhara R., Pazdur R. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clinical Cancer Research 2006, 12:2955-2960.
    • (2006) Clinical Cancer Research , vol.12 , pp. 2955-2960
    • Kane, R.C.1    Farrell, A.T.2    Sridhara, R.3    Pazdur, R.4
  • 18
    • 77956410115 scopus 로고    scopus 로고
    • Selective autophagy: ubiquitin-mediated recognition and beyond
    • Kraft C., Peter M., Hofmann K. Selective autophagy: ubiquitin-mediated recognition and beyond. Nature Cell Biology 2010, 12:836-841.
    • (2010) Nature Cell Biology , vol.12 , pp. 836-841
    • Kraft, C.1    Peter, M.2    Hofmann, K.3
  • 20
    • 25444440875 scopus 로고    scopus 로고
    • The role of autophagy in cancer development and response to therapy
    • Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nature Reviews Cancer 2005, 5:726-734.
    • (2005) Nature Reviews Cancer , vol.5 , pp. 726-734
    • Kondo, Y.1    Kanzawa, T.2    Sawaya, R.3    Kondo, S.4
  • 21
    • 8344242220 scopus 로고    scopus 로고
    • Autophagy in health and disease: a double-edged sword
    • Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
    • (2004) Science , vol.306 , pp. 990-995
    • Shintani, T.1    Klionsky, D.J.2
  • 22
    • 77951750296 scopus 로고    scopus 로고
    • Selective autophagy in cancer development and therapy
    • Dikic I., Johansen T., Kirkin V. Selective autophagy in cancer development and therapy. Cancer Research 2010, 70:3431-3434.
    • (2010) Cancer Research , vol.70 , pp. 3431-3434
    • Dikic, I.1    Johansen, T.2    Kirkin, V.3
  • 24
    • 0346020435 scopus 로고    scopus 로고
    • The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
    • Kawaguchi Y., Kovacs J.J., McLaurin A., Vance J.M., Ito A., Yao T.P. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 2003, 115:727-738.
    • (2003) Cell , vol.115 , pp. 727-738
    • Kawaguchi, Y.1    Kovacs, J.J.2    McLaurin, A.3    Vance, J.M.4    Ito, A.5    Yao, T.P.6
  • 28
    • 77953711220 scopus 로고    scopus 로고
    • Quality control autophagy: a joint effort of ubiquitin, protein deacetylase and actin cytoskeleton
    • Lee J.Y., Yao T.P. Quality control autophagy: a joint effort of ubiquitin, protein deacetylase and actin cytoskeleton. Autophagy 2010, 6:555-557.
    • (2010) Autophagy , vol.6 , pp. 555-557
    • Lee, J.Y.1    Yao, T.P.2
  • 31
    • 33750363298 scopus 로고    scopus 로고
    • The roles of intracellular protein-degradation pathways in neurodegeneration
    • Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443:780-786.
    • (2006) Nature , vol.443 , pp. 780-786
    • Rubinsztein, D.C.1
  • 33
    • 67650517556 scopus 로고    scopus 로고
    • NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets
    • Lamark T., Kirkin V., Dikic I., Johansen T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle 2009, 8:1986-1990.
    • (2009) Cell Cycle , vol.8 , pp. 1986-1990
    • Lamark, T.1    Kirkin, V.2    Dikic, I.3    Johansen, T.4
  • 35
    • 67650234499 scopus 로고    scopus 로고
    • NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets
    • Kirkin V., Lamark T., Johansen T., Dikic I. NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets. Autophagy 2009, 5:732-733.
    • (2009) Autophagy , vol.5 , pp. 732-733
    • Kirkin, V.1    Lamark, T.2    Johansen, T.3    Dikic, I.4
  • 36
    • 80052363973 scopus 로고    scopus 로고
    • Plant NBR1 is a selective autophagy substrate and functional hybrid of the mammalian autophagic adapters NBR1 and p62/SQSTM1
    • Svenning S., Lamark T., Krause K., Johansen T. Plant NBR1 is a selective autophagy substrate and functional hybrid of the mammalian autophagic adapters NBR1 and p62/SQSTM1. Autophagy 2011, 7:993-1010.
    • (2011) Autophagy , vol.7 , pp. 993-1010
    • Svenning, S.1    Lamark, T.2    Krause, K.3    Johansen, T.4
  • 37
    • 33846692198 scopus 로고    scopus 로고
    • Signal integration and diversification through the p62 scaffold protein
    • Moscat J., Diaz-Meco M.T., Wooten M.W. Signal integration and diversification through the p62 scaffold protein. Trends in Biochemical Sciences 2007, 32:95-100.
    • (2007) Trends in Biochemical Sciences , vol.32 , pp. 95-100
    • Moscat, J.1    Diaz-Meco, M.T.2    Wooten, M.W.3
  • 41
    • 60549093730 scopus 로고    scopus 로고
    • Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates
    • Korolchuk V., Mansilla A., Menzies F.M., Rubinsztein D.C. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Molecular Cell 2009, 33:517-527.
    • (2009) Molecular Cell , vol.33 , pp. 517-527
    • Korolchuk, V.1    Mansilla, A.2    Menzies, F.M.3    Rubinsztein, D.C.4
  • 45
    • 77952533111 scopus 로고    scopus 로고
    • VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD
    • Tresse E., Salomons F.A., Bott L.C., Kimonis V., Yao T.P., Dantuma N.P., Taylor J.P. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 2010, 6:217-227.
    • (2010) Autophagy , vol.6 , pp. 217-227
    • Tresse, E.1    Salomons, F.A.2    Bott, L.C.3    Kimonis, V.4    Yao, T.P.5    Dantuma, N.P.6    Taylor, J.P.7
  • 47
    • 0035163063 scopus 로고    scopus 로고
    • Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways
    • Seigneurin-Berny D., Verdel A., Curtet S., Lemercier C., Garin J., Rousseaux S., Khochbin S. Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Molecular and Cell Biology 2001, 21:8035-8044.
    • (2001) Molecular and Cell Biology , vol.21 , pp. 8035-8044
    • Seigneurin-Berny, D.1    Verdel, A.2    Curtet, S.3    Lemercier, C.4    Garin, J.5    Rousseaux, S.6    Khochbin, S.7
  • 49
    • 33344456519 scopus 로고    scopus 로고
    • Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?
    • Lim K.L., Dawson V.L., Dawson T.M. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?. Neurobiology of Aging 2006, 27:524-529.
    • (2006) Neurobiology of Aging , vol.27 , pp. 524-529
    • Lim, K.L.1    Dawson, V.L.2    Dawson, T.M.3
  • 53
    • 34248139628 scopus 로고    scopus 로고
    • Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae
    • Suzuki K., Ohsumi Y. Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. Federation of European Biochemical Societies Letters 2007, 581:2156-2161.
    • (2007) Federation of European Biochemical Societies Letters , vol.581 , pp. 2156-2161
    • Suzuki, K.1    Ohsumi, Y.2
  • 55
    • 33847705665 scopus 로고    scopus 로고
    • Role of ubiquitin- and Ubl-binding proteins in cell signaling
    • Kirkin V., Dikic I. Role of ubiquitin- and Ubl-binding proteins in cell signaling. Current Opinion on Cell Biology 2007, 19:199-205.
    • (2007) Current Opinion on Cell Biology , vol.19 , pp. 199-205
    • Kirkin, V.1    Dikic, I.2
  • 56
    • 0005677775 scopus 로고
    • 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes
    • Seglen P.O., Gordon P.B. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proceedings of the National Academy of Sciences of the United States 1982, 79:1889-1892.
    • (1982) Proceedings of the National Academy of Sciences of the United States , vol.79 , pp. 1889-1892
    • Seglen, P.O.1    Gordon, P.B.2
  • 59
    • 53049083867 scopus 로고    scopus 로고
    • Mechanisms of proteasome inhibitor action and resistance in cancer
    • McConkey D.J., Zhu K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resistance Updates 2008, 11:164-179.
    • (2008) Drug Resistance Updates , vol.11 , pp. 164-179
    • McConkey, D.J.1    Zhu, K.2
  • 60
    • 75149175502 scopus 로고    scopus 로고
    • Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells
    • Zhu K., Dunner K., McConkey D.J. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 2010, 29:451-462.
    • (2010) Oncogene , vol.29 , pp. 451-462
    • Zhu, K.1    Dunner, K.2    McConkey, D.J.3
  • 63
    • 33745859721 scopus 로고    scopus 로고
    • Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection
    • Shacka J.J., Klocke B.J., Roth K.A. Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection. Autophagy 2006, 2:228-230.
    • (2006) Autophagy , vol.2 , pp. 228-230
    • Shacka, J.J.1    Klocke, B.J.2    Roth, K.A.3
  • 65
    • 67651155954 scopus 로고    scopus 로고
    • Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy
    • Ding W.X., Ni H.M., Gao W., Chen X., Kang J.H., Stolz D.B., Liu J., Yin X.M. Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy. Molecular Cancer Therapeutics 2009, 8(7):2036-2045.
    • (2009) Molecular Cancer Therapeutics , vol.8 , Issue.7 , pp. 2036-2045
    • Ding, W.X.1    Ni, H.M.2    Gao, W.3    Chen, X.4    Kang, J.H.5    Stolz, D.B.6    Liu, J.7    Yin, X.M.8
  • 67
    • 79959344464 scopus 로고    scopus 로고
    • Autophaghic and apoptotic effects of HDAC inhibitors on cancer cells
    • Article ID 803260
    • Rikiishi H. Autophaghic and apoptotic effects of HDAC inhibitors on cancer cells. Journal of Biomedicine and Biotechnology 2011, 11. Article ID 803260.
    • (2011) Journal of Biomedicine and Biotechnology , vol.11
    • Rikiishi, H.1
  • 68
    • 67449138841 scopus 로고    scopus 로고
    • Epigenetic modifiers: basic understanding and clinical development
    • Piekarz R.L., Bates S.E. Epigenetic modifiers: basic understanding and clinical development. Clinical Cancer Research 2009, 15:3918-3926.
    • (2009) Clinical Cancer Research , vol.15 , pp. 3918-3926
    • Piekarz, R.L.1    Bates, S.E.2
  • 69
    • 84855424390 scopus 로고    scopus 로고
    • Interplay between histone deacetylases and autophagy - from cancer therapy to neurodegeneration
    • True O., Matthias P. Interplay between histone deacetylases and autophagy - from cancer therapy to neurodegeneration. Immunology and Cell Biology 2012, 90:78-84.
    • (2012) Immunology and Cell Biology , vol.90 , pp. 78-84
    • True, O.1    Matthias, P.2
  • 72
    • 33751172982 scopus 로고    scopus 로고
    • Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells
    • Catley L., Weisberg E., Kiziltepe T., Tai Y.T., Hideshima T., Tassone P., Atadja P., Chauhan D., Munshi N.C., Anderson K.C. Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells. Blood 2006, 108:3441-3449.
    • (2006) Blood , vol.108 , pp. 3441-3449
    • Catley, L.1    Weisberg, E.2    Kiziltepe, T.3    Tai, Y.T.4    Hideshima, T.5    Tassone, P.6    Atadja, P.7    Chauhan, D.8    Munshi, N.C.9    Anderson, K.C.10
  • 73
    • 34347394714 scopus 로고    scopus 로고
    • Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
    • Carew J.S., Nawrocki S.T., Kahue C.N., Zhang H., Yang C., Chung L., Houghton J.A., Huang P., Giles F.J., Cleveland J.L. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007, 110:313-322.
    • (2007) Blood , vol.110 , pp. 313-322
    • Carew, J.S.1    Nawrocki, S.T.2    Kahue, C.N.3    Zhang, H.4    Yang, C.5    Chung, L.6    Houghton, J.A.7    Huang, P.8    Giles, F.J.9    Cleveland, J.L.10
  • 74
    • 79953659370 scopus 로고    scopus 로고
    • Autophagy blockade enhances HDAC inhibitors' pro-apoptotic effects: potential implications for the treatment of a therapeutic-resistant malignancy
    • Lopez G., Torres K., Lev D. Autophagy blockade enhances HDAC inhibitors' pro-apoptotic effects: potential implications for the treatment of a therapeutic-resistant malignancy. Autophagy 2011, 7:440-441.
    • (2011) Autophagy , vol.7 , pp. 440-441
    • Lopez, G.1    Torres, K.2    Lev, D.3
  • 75
    • 77955884095 scopus 로고    scopus 로고
    • Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells
    • Li J., Liu R., Lei Y., Wang K., Lau Q.C., Xie N., Zhou S., Nie C., Chen L., Wei Y., Huang C. Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. Autophagy 2010, 6:711-724.
    • (2010) Autophagy , vol.6 , pp. 711-724
    • Li, J.1    Liu, R.2    Lei, Y.3    Wang, K.4    Lau, Q.C.5    Xie, N.6    Zhou, S.7    Nie, C.8    Chen, L.9    Wei, Y.10    Huang, C.11
  • 76
    • 82955170653 scopus 로고    scopus 로고
    • Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis which is opposed by the induction of autophagy
    • Thomas S., Thurn K.T., Bicaku E., Marchion D.C., Munster P.N. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis which is opposed by the induction of autophagy. Breast Cancer Research and Treatment 2011, 130:437-447.
    • (2011) Breast Cancer Research and Treatment , vol.130 , pp. 437-447
    • Thomas, S.1    Thurn, K.T.2    Bicaku, E.3    Marchion, D.C.4    Munster, P.N.5
  • 78
    • 78649299438 scopus 로고    scopus 로고
    • Autophagy potentiates the anticancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
    • Liu Y.L., Yang P.M., Shun C.T., Wu M.S., Weng J.R., Chen C.C. Autophagy potentiates the anticancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy 2010, 6:1057-1065.
    • (2010) Autophagy , vol.6 , pp. 1057-1065
    • Liu, Y.L.1    Yang, P.M.2    Shun, C.T.3    Wu, M.S.4    Weng, J.R.5    Chen, C.C.6
  • 79
    • 79956003265 scopus 로고    scopus 로고
    • Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy
    • Pan Y., Gao Y., Chen L., Gao G., Dong H., Yang Y., Dong B., Chen X. Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy. Clinical Cancer Research 2011, 17:3248-3258.
    • (2011) Clinical Cancer Research , vol.17 , pp. 3248-3258
    • Pan, Y.1    Gao, Y.2    Chen, L.3    Gao, G.4    Dong, H.5    Yang, Y.6    Dong, B.7    Chen, X.8
  • 81
    • 40449086885 scopus 로고    scopus 로고
    • Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy
    • Apel A., Herr I., Schwarz H., Rodemann H.P., Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Research 2008, 68:1485-1494.
    • (2008) Cancer Research , vol.68 , pp. 1485-1494
    • Apel, A.1    Herr, I.2    Schwarz, H.3    Rodemann, H.P.4    Mayer, A.5
  • 83
    • 69949106925 scopus 로고    scopus 로고
    • The double-edged sword of autophagy modulation in cancer
    • White E., DiPaola R.S. The double-edged sword of autophagy modulation in cancer. Clinical Cancer Research 2009, 15:5308-5316.
    • (2009) Clinical Cancer Research , vol.15 , pp. 5308-5316
    • White, E.1    DiPaola, R.S.2
  • 84
    • 37549056216 scopus 로고    scopus 로고
    • The roles of therapy-induced autophagy and necrosis in cancer treatment
    • Amaravadi R.K., Thompson C.B. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clinical Cancer Research 2007, 13:7271-7279.
    • (2007) Clinical Cancer Research , vol.13 , pp. 7271-7279
    • Amaravadi, R.K.1    Thompson, C.B.2
  • 88
    • 79951690310 scopus 로고    scopus 로고
    • Second generation proteasome inhibitors: carfilzomib and immunoproteasome-specific inhibitors (IPSIs)
    • Kuhn D.J., Orlowski R., Bjorklund C. Second generation proteasome inhibitors: carfilzomib and immunoproteasome-specific inhibitors (IPSIs). Current Cancer Drug Targets 2011, 11:285-295.
    • (2011) Current Cancer Drug Targets , vol.11 , pp. 285-295
    • Kuhn, D.J.1    Orlowski, R.2    Bjorklund, C.3
  • 89
    • 77649237033 scopus 로고    scopus 로고
    • Building on bortezomib: second generation proteasome inhibitors as anti-cancer therapy
    • Dick L.R., Fleming P.E. Building on bortezomib: second generation proteasome inhibitors as anti-cancer therapy. Drug Discovery Today 2010, 15:243-249.
    • (2010) Drug Discovery Today , vol.15 , pp. 243-249
    • Dick, L.R.1    Fleming, P.E.2
  • 92
    • 79959364986 scopus 로고    scopus 로고
    • Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: its association with sequestome 1/p62
    • Myeku N., Figueirido-Pereira M.E. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: its association with sequestome 1/p62. Journal of Biological Chemistry 2011, 286:22426-22440.
    • (2011) Journal of Biological Chemistry , vol.286 , pp. 22426-22440
    • Myeku, N.1    Figueirido-Pereira, M.E.2
  • 93
    • 84864805916 scopus 로고    scopus 로고
    • Autophagy and cancer - issues we need to digest
    • Liu E.Y., Ryan K.M. Autophagy and cancer - issues we need to digest. Journal of Cell Science 2012, 125:1-10.
    • (2012) Journal of Cell Science , vol.125 , pp. 1-10
    • Liu, E.Y.1    Ryan, K.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.